# Lana M. Rifkin, M.D. – FDA Inspection, Mar 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/lana-m-rifkin-md/7a17dbb0-68c1-43db-bb99-a3e52ee3c9d4
Source feed: FDA_Inspections

> FDA inspection 1082930 of Lana M. Rifkin, M.D., March 12, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082930
- Company Name: Lana M. Rifkin, M.D.
- Inspection Date: 2019-03-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/lana-m-rifkin-md/7c237c55-216c-4aff-87fa-2e1adbb78d24

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
